International Conference on Overweight and Diabetes

This session will explore the intricate relationship between obesity and cardiovascular diseases, highlighting the mechanisms through which excess weight contributes to heart-related conditions. Participants will discuss recent findings and potential interventions to mitigate these risks.

This track will focus on the co-morbidity of obesity and diabetes, examining how obesity serves as a significant risk factor for the development of type 2 diabetes. Researchers will present innovative strategies for prevention and management of both conditions.

This session will delve into the association between obesity and various types of cancer, discussing biological pathways and epidemiological evidence. Experts will share insights on prevention strategies and the implications for patient care.

This track will investigate the impact of obesity on endocrine function, including hormonal imbalances that exacerbate weight gain. Discussions will encompass diagnostic approaches and therapeutic options for managing these disorders.

This session will address the effects of obesity on women's health during pregnancy, including potential complications for both mother and child. Researchers will present findings on management strategies to improve outcomes in this population.

This track will focus on the rising prevalence of childhood obesity, emphasizing effective prevention and treatment strategies. Participants will discuss community-based interventions and policy implications for promoting healthier lifestyles among children.

This session will explore the unique challenges associated with obesity in teens and adolescents, including psychological and social factors. Experts will share evidence-based approaches to support weight management in this age group.

This track will examine the role of dietary and lifestyle changes in the prevention and management of obesity. Presentations will highlight successful interventions and the importance of individualized approaches.

This session will review current research on weight loss medications, including their efficacy and safety profiles. Participants will discuss the role of pharmacotherapy in comprehensive obesity management.

This track will focus on the genetic underpinnings of obesity, exploring how hereditary factors influence body weight and fat distribution. Researchers will present findings on genetic testing and personalized treatment approaches.

This session will cover the latest advancements in bariatric surgery, including new techniques and long-term outcomes. Experts will discuss the advantages and potential complications associated with surgical interventions for obesity.